Search
for

    Glossary Sunitinib

    medication that inhibits enzymes to treat certain cancers

    Sunitinib, also known by the brand name Sutent, is a medication used to treat certain types of cancer, including kidney cancer and gastrointestinal stromal tumors. It works by inhibiting multiple protein kinases, which are enzymes involved in the growth and spread of cancer cells.

    Research 10 of 118

    1. Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female World journal of surgical oncology · 2018 · 4 citations
    2. Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario Journal of the advanced practitioner in oncology · 2018
    3. Sunitinib Reactions Weekly · 2012
    4. 710 BIOMARKERS OF SUNITNIB CLINICAL RESPONSE IN METASTATIC RENAL CLEAR CELL CARCINOMA PATIENTS European Urology Supplements · 2009
    5. Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects Current drug metabolism · 2009 · 508 citations
    6. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    7. Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans Journal of Pharmacology and Experimental Therapeutics · 2003 · 73 citations
    8. Advances in the Management of Cutaneous Toxicities of Targeted Therapies Seminars in Oncology · 2012 · 42 citations
    9. Adverse Hair Reactions to New Targeted Therapies for Cancer Actas Dermo-Sifiliográficas · 2019 · 1 citations
    10. KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning Pharmaceuticals · 2026
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →